RAGE expression and AGE-induced MAP kinase activation in Caco-2 cells

Area of Science:

• Cell biology
• Molecular biology
• Biochemistry

Background:

• Receptor for advanced glycation end products (RAGE) is a cell surface receptor involved in various diseases.
• RAGE binds to advanced glycation end products (AGEs), which accumulate in conditions like diabetes and renal failure.
• The p44/42 (ERK1/2) MAP kinase pathway is a critical signaling cascade activated by RAGE ligation.

Purpose of the Study:

• To investigate RAGE expression in the human colon adenocarcinoma cell line Caco-2.
• To determine the effect of advanced glycation end products (AGEs) on Caco-2 cells.
• To analyze the activation of p44/42 (ERK1/2) MAP kinases in response to AGEs in Caco-2 cells.

Main Methods:

• Reverse transcription polymerase chain reaction (RT-PCR) to assess RAGE gene expression.
• Western blot analysis to confirm RAGE protein expression.
• Cell culture experiments involving incubation with food-derived AGEs (Cas-CML) and subsequent kinase activity assays.

Main Results:

• Caco-2 cells were confirmed to express RAGE at both the mRNA and protein levels.
• Incubation of Caco-2 cells with casein-linked AGEs (Cas-CML) led to the activation of p44/42 (ERK1/2) MAP kinases.
• This study provides the first evidence of RAGE expression and AGE-induced signaling in Caco-2 cells.

Conclusions:

• Caco-2 cells express functional RAGE, indicating their potential role in AGE-related cellular responses.
• AGEs, specifically Cas-CML, can activate the p44/42 (ERK1/2) MAP kinase pathway in colon adenocarcinoma cells.
• These findings contribute to understanding the molecular mechanisms underlying RAGE signaling in colon cancer.